Pain and Pain Symptom Management for Michigan Nurses
Online Continuing Education Course

Course Description
MANDATORY MICHIGAN NURSING CEU. This nursing CEU course fulfills the requirement for 2 contact hours in pain and symptom management for each MI nursing license renewal. Covers understanding and responding to misuse, abuse, and diversion of opioids in providing pain management; assessing risk for substance abuse disorders; and efforts to address the problem.
Course Price: $20.00
Contact Hours: 2
Pharmacotherapeutic Hours: 0.25
Course updated on
August 1, 2025
"I am happy to say that I learned things in this course. That's always a good thing when the subject matter is mandatory. Very good course." - Kathleen, RN in Michigan
"Excellent review, with updated information, recommendations, resources, and strategies." - Donna, RN in Michigan
"Excellent and comprehensive. Thank you." - Linda, RN in Michigan
"Good detail and appropriate to Michigan requirements." - Rachel, RN in Michigan
Pain and Pain Symptom Management for Michigan Nurses
Copyright © 2025 Wild Iris Medical Education, Inc. All Rights Reserved.
LEARNING OUTCOME AND OBJECTIVES: Upon completion of this course, you will better understand the experience of pain, appropriate assessment and interventions for pain, and issues regarding opioid use. Specific learning objectives to address potential knowledge gaps include:
- Discuss pain and the experience of pain.
- Outline the elements of a comprehensive pain assessment.
- Describe pharmacologic and nonpharmacologic interventions for pain.
- Summarize issues concerning the use of controlled substances in pain management.
TABLE OF CONTENTS
INTRODUCTION
Modern pain research began in the 1960s, and in recent decades, there has been a change in the perception of pain that has profoundly influenced scientific and medical pain research and treatment. Pain is no longer viewed as a symptom but rather a disease in and of itself. Its occurrence, severity, duration, response to treatment, and disabling consequences vary from person to person. Like other diseases, pain is more than a biological phenomenon; it has profound emotional and cognitive effects.
In 2010, the Council of the International Association for the Study of Pain (IASP) issued the Declaration of Montreal, which asserts that “withholding of pain treatment is profoundly wrong, leading to unnecessary suffering which is harmful.” The Declaration further asserts:
- Article 1. The right of all people to have access to pain management without discrimination
- Article 2. The right of people in pain to acknowledgment of their pain and to be informed about how it can be assessed and managed
- Article 3. The right of all people with pain to have access to appropriate assessment and treatment of the pain by adequately trained healthcare professionals
(IASP, 2021a)
To meet this obligation, effective management of pain requires an in-depth knowledge of the complexity of the pain experience, enhanced assessment skills, treatment modalities currently available, and policies that affect how these modalities may be utilized.
The CDC reported that, in 2023, 24.3% of U.S. adults had chronic pain and 8.5% had chronic pain that frequently limited life or work activities (referred to as high-impact chronic pain) in the past three months. Chronic pain and high-impact chronic pain are associated with decreased quality of life, opioid dependence, and poor mental health.
THE EXPERIENCE OF PAIN
Pain is the most common reason people seek medical care (NCCIH, 2025). It is a complex experience that includes a physiologic and a psychological response to noxious stimuli. It is a warning mechanism protecting an individual by influencing them to withdraw from harmful stimuli and is primarily associated with injury or the threat of injury.
Pain is subjective and difficult to quantify, as it has both affective and sensory components. The neuroanatomic basis of pain reception develops before birth, and individual pain responses are learned in early childhood. These responses are affected by social, cultural, psychological, cognitive, and genetic factors (Meldrum, 2025).
What Is Pain?
In 1979 the International Association for the Study of Pain defined pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.” The newer 2020 definition (below) replaces terminology that relied on a person’s ability to describe the experience to qualify as pain. Unlike the older definition, the newer definition includes infants, elderly people, and others—even animals—who cannot verbally articulate their pain.
- Pain is always a personal experience that is influenced to varying degrees by biological, psychological, and social factors.
- Pain and the detection of painful stimuli are different phenomena. Pain cannot be inferred solely from activity in sensory neurons.
- Through their life experiences, individuals learn the concept of pain.
- A person’s report of an experience as pain should be respected.
- Although pain usually serves an adaptive role, it may have adverse effects on function and social and psychological well-being.
- Verbal description is only one of several behaviors to express pain; inability to communicate does not negate the possibility that a human or a nonhuman animal experiences pain.
(IASP, 2021)
Pain alters the quality of life more than any other health-related problem. It interferes with sleep, mobility, nutrition, thought, sexual activity, emotional well-being, creativity, and self-actualization. Surprisingly, even though pain is such an important obstacle to a patient’s comfort, it is one of the least understood, most undertreated, and oft-discounted problems of healthcare providers and their patients.
PAIN-RELATED TERMINOLOGY
Allodynia
Pain due to a stimulus that does not normally provoke pain
Analgesia
Absence of pain in response to stimulation that would normally be painful
Causalgia
A syndrome of sustained burning pain, allodynia, and hyperpathia after a traumatic nerve lesion
Dysesthesia
An unpleasant abnormal sensation, whether spontaneous or evoked
Hyperalgesia
Increased pain from a stimulus that normally provokes pain
Hyperpathia
A painful syndrome characterized by an abnormally painful reaction to a stimulus, especially a repetitive stimulus, as well as an increased threshold
Hypoalgesia
Diminished pain in response to a normally painful stimulus
Neuralgia
Pain in the distribution of a nerve or nerves
Neuropathic pain
Pain caused by a lesion or disease of the somatosensory nervous system
Nociception pain
Pain arising from actual or threatened damage to non-neural tissue due to the activation of nociceptors (high-threshold sensory receptors of the peripheral somatosensory nervous system)
Pain threshold
Amount of pain required before individuals feel the pain; the lower the threshold, the less pain can be endured; the higher the threshold, the more pain can be endured
Pain tolerance level
Maximum intensity of a pain-producing stimulus that a subject is willing to accept in a given situation; the subjective experience of the individual
Paresthesia
An abnormal sensation whether spontaneous or evoked
(IASP, 2021a)
Classification of Pain
The classification of pain is complicated, and there are several different classification systems, many of which overlap. Among other characteristics, pain can be classified by duration and source.
BY DURATION
Pain is classified by duration as acute or chronic.
Acute Pain
Acute pain is protective in that it motivates a person to take action immediately. Acute pain is caused by noxious stimulation due to injury, a disease process, or the abnormal function of muscle or viscera. Acute pain begins suddenly, is usually sharp in quality, and correlates with the amount of damage. It is temporary and subsides as healing takes place. In acute pain, the central nervous system is intact and acute pain is a symptom. Examples of causes of acute pain include:
- Surgery
- Broken bones
- Dental work
- Burns or cuts
- Labor and childbirth
There are two types of acute pain:
- Somatic pain results from superficial injury to skin and subcutaneous tissue (e.g., burns, cut, abrasions) or deep injury to muscle, bone, joint, and connective tissues (e.g., fractures, arthritis, fibrositis, rupture of muscle belly).
- Visceral pain results from injury to the internal organs (e.g., peptic ulcer, angina pectoris, renal colic).
In most instances, acute pain does not last longer than six months and disappears when the underlying cause of pain has been treated or has healed. Psychological effects of unrelieved pain can lead to anxiety and depression, and unrelieved acute pain may lead to chronic pain (TEMA Therapy Center, 2025).
Chronic Pain
Chronic pain is ongoing and usually lasts longer than six months. This type of pain continues even after the injury or illness that caused it has healed. Chronic pain persists, recurs, or progresses over a long period of time and is often resistant to medical treatments. Pain signals remain active in the nervous system for weeks, months, or years. Some people suffer chronic pain even when there is no past injury or apparent body damage. Chronic pain is linked to such conditions as:
- Headache
- Arthritis and other musculoskeletal conditions
- Cancer
- Chemotherapy/radiation
- Nerve pain
- Back pain
- Fibromyalgia
- Surgical complications
With chronic pain, stress affects the body, producing physical conditions such as tense muscles, limited ability to move about, lack of energy, and changes in appetite. Chronic pain also causes emotional effects that may include depression, anger, anxiety, mood disorders, and isolation (Cleveland Clinic, 2022; TEMA Therapy Center, 2025).
BY SOURCE
The sources (causes) of pain are divided into the categories of nociceptor, neuropathic, psychogenic, and idiopathic.
Nociceptor Pain
Nociceptor pain is acute pain that results when tissue damage produces a stimulus that sends an electrical impulse across a receptor (nociceptor) by way of a nerve fiber to the central nervous system. Receptors for this type of pain are located all around the body, particularly under the skin and the internal organs. Some body tissues, such as the brain and lung, have no nociceptors, and some tissues have many.
Nociceptive pain can be divided into those that are sustained by injury to somatic tissues (bone, joints, or muscles) and those that are sustained by injury to visceral tissues. Somatic pain is often described as aching, stabbing, throbbing, or pressurelike. Visceral pain is usually described as gnawing or crampy when arising from obstruction of a hollow organ such as the bowel and as aching or stabbing when arising from other internal organs (Portenoy & Dhingra, 2022).
Nociplastic Pain
Nociplastic pain arises from altered nociception despite the absence of clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors or evidence for disease or lesion of the somatosensory system. This type of pain may reflect changes in the way the nervous and immune systems function (Slater & Davies, 2023).
Neuropathic Pain
Neuropathic pain results from damage to or dysfunction of the peripheral or central nervous system rather than from stimulation of pain receptors. Mechanisms of neuropathic pain are complex and involve certain types of changes:
- At the peripheral nociceptor and nerve level
- At the dorsal root ganglion (DRG)
- In the central nervous system (CNS)
One example of neuropathic pain is phantom limb syndrome, which can occur following an amputation and when the brain continues to receive pain messages that originally carried impulses from the missing limb (Ability KC, 2025). (See “Mirror Therapy” later in this course.)
Radicular Pain
Radicular pain is a very specific type of pain that can occur when the spinal nerve becomes compressed or inflamed. It radiates from the back and hip to the leg(s) by way of the spine and spinal nerve root. People with radicular pain may experience tingling, numbness, and muscle weakness (Beaumont Health, 2024).
Psychogenic Pain
Psychogenic pain is believed to be sustained mainly by psychological factors. It does not refer to the common idea that pain experienced by some patients is exacerbated by psychological factors or the finding of high pain-related distress or comorbid psychiatric disease. Instead, it implies that the pain is best understood as a result of psychological processes. It is classified as a somatic symptom disorder with prominent pain, which is diagnosed on the basis of excessive thoughts, feelings, or behaviors related to pain that are distressing, impair function, and appear out of proportion to physical findings.
It must be remembered that psychogenic pain is truly experienced and is not a deception. This distinguishes it from disorders that reflect a serious mental disorder in which reports of pain may not indicate a true experience of pain and from malingering (Portenoy & Dhingra, 2022).
Idiopathic Pain
Idiopathic pain (also called pain of unknown origin) is chronic pain lasting six months or longer that has no identifiable cause. Although its origin is often unknown, idiopathic pain is very real. It is also possible for this type of pain to remain long after a medical condition has healed when pain normally should have ended (Fortis Healthcare, 2025; Sureja, 2025).
Factors That Influence the Experience of Pain
The experience of pain is influenced by both physiologic and psychosocial factors, all of which clinicians must consider in pain management. Physiologic factors that influence pain include age, gender, genetic makeup, and stress response. Psychosocial factors include the person’s personality, the meaning ascribed to pain by an individual, fear and catastrophizing, and emotional distress.
PAIN ASSESSMENT
A precise and systematic assessment of pain is important for making an accurate diagnosis and for the development of an effective treatment plan. Pain is a multidimensional phenomenon that produces strong emotional reactions that can affect an individual’s function, quality of life, emotional state, social and vocational status, and general well-being. Therefore, it is recommended that pain be assessed using a multidimensional approach and that these various impacts be addressed and included in the diagnostic formulation.
A comprehensive pain assessment includes a history of the pain, behavioral observations, past medical history, medications, family history, a physical examination, and, if necessary, diagnostic testing.
Pain History
A pain assessment begins with the history of the problem and can be obtained from written documents and from interviews with the person in pain as well as family members and other caregivers. Pain is a subjective symptom, and pain assessment is, therefore, based on the patient’s own perception of pain and its severity.
ELEMENTS OF PAIN HISTORY
Because pain is subjective, a self-report is considered the “gold standard,” or the best, most accurate measure of a person’s pain. One method to obtain a complete pain history is the PQRST assessment (see below).
PQRST PAIN ASSESSMENT
Provocation/Palliation (P)
- What were you doing when the pain started?
- What caused the pain?
- What seems to trigger it (e.g., stress, position, certain activities)?
- What relieves it (e.g., medications, massage, heat/cold, changing position, being active, resting)?
- What aggravates it (e.g., movement, bending, lying down, walking, standing)?
Quality/Quantity (Q)
- What does the pain feel like (e.g., sharp, dull, stabbing, burning, crushing, throbbing, nauseating, shooting, twisting, stretching)?
Region/Radiation (R)
- Where is the pain located?
- Does the pain radiate and, if so, where?
- Does the pain feel like it travels/moves around?
- Did it start somewhere else and is now localized to another spot?
- Is it accompanied by other signs and symptoms?
Severity Scale (S)
- How severe is the pain on a scale of 0–10, with 0 as no pain and 10 as the worst pain ever?
- Does the pain interfere with activities?
- How bad is the pain at its worst?
- Does it force you to sit down, lie down, or slow down?
- How long does an episode last?
Timing (T)
- When or at what time did the pain begin?
- How long did it last?
- How often does it occur (e.g., hourly, daily, weekly, monthly)?
- Is the pain sudden or gradual in onset?
- When do you usually experience it (e.g., daytime, night, early morning)?
- Are you ever awakened by it?
- Does it ever occur before, during, or after meals?
- Does it occur seasonally?
(Crozer Health, 2022)
Behavioral Observations
Most people who are experiencing pain usually show it either by verbal complaint or nonverbal behaviors or indicators. It is important, however, to remember that people in pain may or may not display behaviors that are considered an indication of “being in pain,” and making judgments about their honesty is inappropriate.
Nonverbal indicators of pain may include:
- Facial expressions
- Vocalizations
- Body movements
- Activity/routine changes
- Alterations in social interactions
- Protective movements
- Mental status changes
- Physiological changes
(Toney-Butler, 2023; Victoria Department of Health, 2024)
Medical and Surgical History
Relevant past medical and surgical history may help determine the etiology of pain (e.g., diabetes, history of cancer, rheumatic disease) and may reveal conditions that affect the choice of therapy. This includes:
- Prior medical illness (e.g., renal or hepatic insufficiency/disease, which affects choice of analgesic and dosing)
- Prior psychiatric illnesses (e.g., depression or anxiety)
- Prior surgeries, scarring, repeated surgeries (may increase sensitivity to pain)
- Past injuries and accidents
- Coexisting acute or chronic illnesses
- Chemical dependence
- Prior problems with pain and treatment outcomes
- Investigations conducted (e.g., medical imaging)
A complete list of current medications (past and present) and usage, including over-the-counter medications and alternative, herbal, and natural products, is obtained, as well as the patient’s report of their effectiveness. Evaluation of physiologic tolerance (diminished response) related to chronic use of some medications and use of alcohol and illicit drugs is also included.
Family history is important, as it may give a clue to any predisposition to pain-causing illnesses and conditions that may involve the connective tissues (e.g., kyphoscoliosis), metabolism (e.g., sickle cell disease), and neurologic system (e.g., familial amyloid neuropathy). Other types of disorders that may cluster in families include fibromyalgia, persistent back pain, irritable bowel syndrome, and some types of arthritis (Farrell et al., 2023).
Review of Systems
The review of systems may suggest conditions that are associated with nociplastic sensory hypersensitivity (pain with no clear evidence as to source) and may support a syndromic pain diagnosis, such as chronic fatigue, headache, or widespread conditions like fibromyalgia (Tauben & Stacey, 2025).
The psychosocial history is an important aspect to a review of systems because what first appears to be a simple problem can become much more complex due to the influence of psychological and social factors. A psychosocial history includes:
- Psychological history (emotional state, personality, self-esteem)
- History of mental illness and past traumatic experiences
- Family systems
- Social history (economic factors, education, social class, culture/ethnicity)
(CRLN, 2024)
Functional Assessment
Components of a functional assessment include:
- Ability to complete activities of daily living
- Mood/mental health
- Mobility
- Work ability
- Sleep
- Relations with other people
(Borras-Fernandez et al., 2025)
Physical Examination
A systematic, targeted, pain-focused physical examination is most fruitful when the pain history interview and behavioral observations are conducted at the same time. Because pain may be referred from some other area of the body, the examination includes a full visual scan from head to toe.
- Mental status examination
- Vitals signs
- General inspection
- Auscultation of the lungs, heart, and bowel sounds
- Palpation and touch
- Musculoskeletal examination
- Neurologic examination
- Abdominal, pelvic, or rectal examination
(Tauben & Stacey, 2025)
Diagnostic Testing
Although there are no diagnostic tests available as yet to determine how much pain a person is experiencing and no test that can measure the intensity or location of pain, there are a number of tests that can be performed to determine the cause or source of pain.
LABORATORY TESTS
Routine blood studies are not indicated, but directed testing should be ordered when specific causes of pain are suggested by the patient’s history or physical examination.
- Complete blood count (CBC)
- Comprehensive metabolic panel (CMP)
- Erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
- Vitamin B12, B6, and folate levels
- Fasting blood sugar (FBS) and glycated hemoglobin (HbA1C)
- Hemoglobin S
- HIV antibodies
- HSV antibodies
- Lyme antibody testing
- Rheumatologic tests
- HLA B27 antigen
(Jimenez, 2025; Nnanna, 2022)
IMAGING AND ELECTRODIAGNOSTIC TESTING
- Plain X-ray films
- Ultrasound
- Myelograms
- Computerized tomography (CT)
- Discogram
- Magnetic resonance imaging (MRI)
- 18-FDG PET and MRI (a newer PET/MRI method)
- Functional MRI
- Bone scans
- Electromyography (EMG)
(Gooch & Henderson, 2025; Wheeler, 2023)
Psychological Examination
A psychological assessment is intended to identify emotional reactions, maladaptive thinking and behavior, and social problems that can contribute to pain and disability. A psychological assessment includes a semistructured clinical interview and self-report instrument to assess differences in the domains of pain experience, functional impairment, and pain-related disability (Comprehensive MedPsych Systems, 2025; Jamison & Craig, 2022).
PAIN AND RISK FOR SUICIDE
Chronic pain is prevalent in people who die by suicide. Chronic, nonmalignant pain, independent of other factors such as sociodemographic and physical and mental health status, doubles the risk of suicide. Risk factors for suicidal ideation and behavior in those with chronic pain include:
- Multiple pain conditions
- Severe pain
- More frequent episodes of intermittent pain (e.g., migraines)
- Longer duration of pain
- Sleep onset insomnia
Psychological processes relevant to patients with chronic pain who may be at risk for suicide include helplessness and hopelessness, a desire to escape the pain, and problem-solving deficit. Evaluation should include patient and family past histories of suicidal ideation and behavior (Schreiber & Culpepper, 2023).
STRATEGIES FOR TREATING AND MANAGING PAIN
A comprehensive pain management approach includes:
- Appropriate pharmacologic and nonpharmacologic interventions
- Education of patient, family, and caregivers about the plan
- Ongoing assessment of treatment outcomes
- Regular review of the treatment plan
Pharmacologic Interventions
Pharmacologic interventions can be broadly categorized as primary analgesic medications and adjuvant (coanalgesic, or “helper”) medications. Analgesics include nonopioid analgesics and opioid analgesics. Nonopioids are non-narcotic analgesics used to treat mild pain and also to serve as adjuvant medication for relief of moderate to severe pain. They include acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs); many are available over the counter, while some are available by prescription only. Opioids are narcotics used for moderate to severe pain. Cannabinoids are a unique class of drugs that may be used for pain and do not fit into these categories.
OPIOID ANALGESICS
Opiates are refined from the opium poppy (Papaver somniferum) and include opium, morphine, codeine, and heroin. Opioid analgesics are synthesized compounds that are chemically similar to opiates. Examples include:
- Oxycodone
- Hydrocodone
- Oxymorphone
- Buprenorphine
Other synthesized drugs that mimic the effects of opiates but are not derived from the opium poppy include methadone, fentanyl, and meperidine (OR ADPC, 2025).
Opioids and Drug Tolerance, Dependence, and Addiction
When an opioid drug is used on a regular basis, generally after more than two to three weeks, the same dose of the drug has less of an effect. This is referred to as tolerance. A person who is developing tolerance may require larger amounts of the drug to get the same effect.
With repeated use of opioids and the development of tolerance, dependence occurs. Dependence is characterized by the symptoms of tolerance and withdrawal. The brain adapts to repeated exposure to the drug and can only function normally in the presence of the drug. When the drug is withdrawn, physiologic reactions occur, which can be mild or even life-threatening.
Drug addiction is a state of psychological or physical dependence on the use of drugs. Biologic, psychological, social, and environmental factors influence its development and maintenance. About half the risk for addiction is genetic (APA, 2025; Bukstein, 2024; Sevarino, 2023).
NEW NONOPIOD PAIN MEDICATION
In January 2025, the FDA approved a first-in-class nonopioid pain therapy called suzetrigine (Journavx). The medication is the first selective NaV1.8 pain signal inhibitor approved for moderate to severe acute pain in adults. Suzetrigine is not only the first drug in the selective NaV1.8 pain signal inhibitors class, but also it is the first new drug in 20 years to be approved for the treatment of acute pain. The medication targets sodium channels in the peripheral nervous system, blocking pain signals before they reach the brain, which reduces the risk of addiction.
Journavx is dispensed in 50 mg tablets, and the medication is taken every 12 hours after the primary dose. Potential side effects include itching, muscle spasms, rash, and increased creatine phosphokinase blood levels (Drugs.com, 2025; U.S. FDA, 2025; Vertex, 2025).
ADJUVANT ANALGESICS
Adjuvant analgesics (coanalgesics) are drugs that were developed for clinical uses other than pain but due to their analgesic effects are used to manage pain in select circumstances. Adjuvant analgesics can be used on their own or in conjunction with pain medications. Common adjuvant analgesics include:
- Antidepressants
- Anticonvulsants
- Antispasmodics
- Antihypertensives
- Osteoclast inhibitors
- Radiopharmaceuticals
- Anxiolytics
- Neurotoxins
- Topical anesthetics
- Corticosteroids
- Anesthetic drugs
- Cannabinoids
- Anticholinergics
(Portenoy et al., 2022)
CANNABIS (MEDICAL MARIJUANA)
Nearly all states, including Michigan, have medical cannabis laws, and 93% of Americans support medical cannabis. However, federal law continues to prohibit use of cannabis or its derivatives for any purpose. This means that people may be arrested and charged with possession even in states where marijuana use is legal (ASA, 2023; NIDA, 2025).
Michigan laws regarding medical marijuana state:
- An adult may possess up to 2.5 ounces of marijuana, up to 15 grams of which may be marijuana concentrate.
- Within a residence, an adult may possess up to 10 ounces of marijuana and any marijuana produced by marijuana cultivated on the premises.
- An individual can cultivate less than 12 plants for personal use.
- An adult may transfer up to 2.5 ounces of marijuana to another adult as long as there is no remuneration and the transfer is not advertised or promoted to the public.
(NORML, 2025)
Nonpharmacologic Interventions
Evidence-based nonpharmacologic therapies are safe when correctly administered and can be effective components of comprehensive pain management that can reduce the need for opioids. Nonpharmacologic therapies can be the sole intervention, or they can be combined with other treatments. Nonpharmacologic interventions include physical, psychological, and mind–body modalities.
PHYSICAL MODALITIES
Physical modalities for relief of pain refer to any therapeutic medium that uses the transmission to or through the patient of thermal, electrical, acoustic, radiant, or mechanical energy.
- Thermal modalities (heat and cold)
- Manual modalities (massage, manipulation therapy)
- Acupuncture
- Electro-physical agents (transcutaneous electrical nerve stimulation, interferential stimulation, percutaneous electric nerve stimulation, pulse electromagnetic field stimulation, iontophoresis)
- Acoustic modalities (ultrasound, shortwave and microwave diathermy, phonophoresis, vibroacoustic therapy)
- Light therapy (low-level laser, ultraviolet light)
- Interventional modalities (injection, radiofrequency ablation, cryotherapy ablation, intrathecal pump implants, spinal cord stimulator, intradiscal electrothermal therapy, dry needling)
(APTA, 2021; Mayo Clinic, 2024b; Wood, 2025)
PSYCHOLOGICAL MODALITIES
Cognitive-behavioral therapy (CBT) is the prevailing psychological treatment for individuals with a wide variety of chronic pain issues. It can be used alone or in conjunction with medical or interdisciplinary rehabilitation treatments. CBT practice varies but often includes relaxation training, setting and working toward behavioral goals, behavioral activation, guidance in activity pacing, problem-solving training, and cognitive restructuring. The role of CBT is to help patients recognize the emotional and psychological factors that influence pain perception and the behaviors associated with having pain (Physiopedia, 2025a).
Acceptance and commitment therapy (ACT) helps patients to shift their primary focus from reducing or eliminating pain to fully engaging in their lives. The goal of the therapy is to help patients accept whatever discomfort exists, both physical and emotional, while continuing to live their lives according to their values (Glasofer, 2024).
MIND–BODY TECHNIQUES
Biofeedback is the use of instrumentation to mirror psychophysiologic processes, such as blood pressure, heart rate, and skin temperature, of which an individual normally is unaware and which may be brought under voluntary control. Researchers aren’t exactly sure how or why biofeedback works, but they do know that it promotes relaxation, which can help relieve many conditions related to stress.
Types of biofeedback devices include:
- Electromyogram (EMG)
- Thermal
- Neurofeedback or electroencephalography (EEG)
- Electrodermal activity (ADA)
- Heart rate variability (HRA)
(Watson, 2024)
Relaxation therapies have been found helpful in the management of chronic headaches and other types of chronic pain. Relaxation encourages reduction in muscle tension, resulting in a decrease in pain intensity. Practices may include progressive relaxation, autogenic training, guided imagery, self-hypnosis, and deep-breathing exercises. The goal is similar for all: to produce the body’s natural relaxation response, characterized by slower breathing, lower blood pressure, and a feeling of increased well-being (Dunkin, 2024; Mayo Clinic, 2024a).
Hypnosis is a procedure involving cognitive processes in which the patient is guided by a health professional to respond to suggestions for changes in perceptions, sensations, thoughts, feelings, and behaviors. It involves learning how to use the mind and thoughts to manage emotional distress, unpleasant physical symptoms, and certain habits or behaviors. Researchers analyzed 18 studies that explored the effects of hypnosis on pain relief and found that the practice yielded moderate to significant results, thus supporting its use in relieving pain (Dunkin, 2024).
Distraction permits the patient to shift their attention away from pain or painful stimuli to something more engaging or enjoyable. Distraction techniques can be internal (e.g., imagery) or external to the individual, such as audio (e.g., music), visual (e.g., book), or audiovisual (e.g., movies). They may require passive or interactive engagement and involve others (e.g., healthcare providers, parents). Older children and adults may find watching TV or listening to music helpful (Stanford Health Care, 2025).
Mindfulness-based interventions (e.g., meditation) have been found to have significant effects on chronic pain, yet the mechanisms underlying these effects are not well understood. Types of mindfulness-based interventions include:
- Mindfulness-based stress reduction (MBSR)
- Mindfulness-based cognitive therapy (MCBT)
- Primary care brief mindfulness training (PCBMT)
- Mindfulness-based exposure therapy (MBET)
- Mantra-based meditation training
(Lucchetti, 2023; Robles et al., 2024)
Virtual reality therapies have been shown to effectively distract patients who suffer from chronic and acute pain. Virtual reality is a computer-generated world that simulates real-life experiences through senses and perception. An individual using VR equipment is able to look around the artificial world, move around in it, and interact with virtual features or even thoughts.
Virtual reality provides immersive experiences that absorb more of the brain’s attention. With fewer mental resources left to process pain signals, people perceive less pain (Eley, 2023; Maddox et al., 2025).
Mirror therapy is a rehabilitation therapy in which a mirror is placed between the arms or legs so that the image of a moving, nonaffected limb gives the illusion of normal movement in the affected limb. Mirror therapy exploits the brain’s preference to prioritize visual feedback over somatosensory/proprioceptive feedback concerning limb position. The reflection “tricks” the brain into thinking there are two healthy limbs (Physiopedia, 2025b).

Using a mirror, the brain is “tricked” into seeing two limbs. (Source: © Sköld et al., 2011.)
Yoga is a mind–body and exercise practice that helps relieve chronic pain. Yoga has many of the same benefits as mindfulness practice due to the common focus on breath, body, and present-moment awareness. There are different types of yoga, with the most evidence of benefit being shown through Iyengar yoga, hatha yoga, and Viniyoga (DHWA, 2023).
Tai chi and qigong are forms of traditional Chinese exercise that incorporate the concepts of two opposing forces—yin and yang. Both exercises are based on the idea and core principle that increasing energy (chi) in the body through gentle and repeated movements can enhance a person’s well-being. Pain or sickness is believed to occur when the flow of chi is blocked or when yin and yang energies are out of balance. The joints are seen as gates that control the flow of chi and that can be opened by using slow and gentle swaying movements, deep breathing, and mental focus (LeWine 2024; Marks, 2022).
Evaluating the Effectiveness of Interventions
There are multiple outcome measures required to adequately assess the pain experience and how it has been modified by pain management interventions. The outcome of pain management is done by assessing:
- Duration of the analgesic effect
- Pain intensity at rest and during activity
- Measures of physical functioning
- Measures of emotional functioning
- Adverse events related to the treatment
(Pogatzki-Zahn et al., 2025)
Nursing Principles of Pain Management
Many disciplines are involved in managing a patient’s pain, and nurses play a pivotal role in the assessment, monitoring, interpretation, and evaluation of pain. Effective pain management by nurses is fundamental to quality of care and is the first responsibility of the nurse.
Nursing functions of appropriate pain management include:
- Ensuring the patient or legal representative actively participates in treatment plan and understands available options and potential side effects
- Educating persons and families in a culturally competent manner regarding pain management
- Using a standardized scale to periodically assess and document the patient’s pain
- Developing and implementing a plan of care that prevents and alleviates pain as much as possible
- Administering medications and treatment as prescribed
- Initiating nonpharmacologic nursing interventions as indicated
- Serving as an advocate for the patient
- Communicating side effects or reports of unrelieved pain to the prescriber and team members
- Documenting pain assessment, intervention, evaluation, and ongoing changes
(State of Michigan Department of Community Health, n.d.)
NURSING PRINCIPLES OF PAIN MANAGEMENT USING CONTROLLED SUBSTANCES
- All persons experiencing pain have a right to pain relief.
- A person’s report of pain is the optimal standard for all interventions.
- A comprehensive nursing assessment must be completed, including subjective description of pain, objective data, and identified need for psychosocial/spiritual support.
- Fear of addiction of opioids and other pain medications should not be a barrier to pain management.
- Nurses recognize and apply the following concepts when providing care:
- Tolerance and physical dependence are consequences of sustained use of opioid analgesics and are not symptoms of addiction.
- Pseudo-addiction is a pattern of drug-seeking behavior by persons with pain who are fearful of receiving inadequate pain management and may be mistaken for addiction.
- Persons with a history of substance abuse have a right to adequate pain relief even if opioids must be used.
- An interdisciplinary approach is optimal.
- Pain management continues even if the person becomes unresponsive.
(State of Michigan Department of Community Health, n.d.)
OPIOID MISUSE, ABUSE, AND DIVERSION
Along with attempts to improve identification and treatment of pain, there has been a rise in prescription opioid addiction and abuse in the United States. Opioid misuse, abuse, and diversion are major problems with serious consequences, and the efforts to address them involve government and regulatory agencies, drug researchers and manufacturers, healthcare institutions, and individual clinicians.
Drug diversion can be defined as any act or deviation that removes a prescription drug from its intended path from the manufacturer to the intended patient. When diversion of controlled substances occurs in the healthcare setting, patient safety issues, harm to the diverter, and risk of liability to the organization can occur (ASHP, 2025).
Scope of the Problem
According to government agencies that research and report findings about drug abuse:
- Almost 50% of American adults report using a prescription drug, legally or not, during the past month.
- Four out of five pharmacy-filled prescriptions are opioids.
- Six percent of Americans over the age of 12 abuse prescriptions each year, and 12% of prescription drug abusers are addicted.
- Among people ages 12 and older in 2020, an estimated 2.3 million people in the United States had a prescription opioid use disorder in the past year.
- Nearly 92,000 persons in the United States died from drug-involved overdose in 2020 due to illicit drugs and prescription opioids. The national overdose deaths involving prescription opioids among all ages in 2020 was 16,416.
- Among young people in 2021, an estimated 4.4% of 12th graders reported misusing any prescription drug in the past 12 months.
- In 2020, 50,000 individuals used heroin for the first time, and 14,480 deaths from heroin occurred.
(NCDAS, 2025; NIDA, 2023b)
The state of Michigan previously ranked in the top third nationally for drug-related deaths, with over half due to synthetic opioids, mainly fentanyl.
- In 2021 there were 2,536 opioid overdose deaths in Michigan, which accounted for 82% of all drug overdose deaths in the state.
- From 2011 to 2021, the death rate due to opioid overdose increased from 7.5 per 100,000 to 26.0 per 100,000 in Michigan.
More recently, the Michigan Department of Health and Human Services (MDHHS) reported a 34% reduction in opioid overdose deaths between 2023 and 2024, which equates to roughly 1,000 lives saved. Michigan has used its $1.6 billion from the national opioid settlements with pharmaceutical companies and retail pharmacies to support prevention, treatment, recovery, and harm-reduction efforts in the state’s local communities (KFF, 2025; MDHHS, 2025b).
CDC GUIDELINES FOR PRESCRIBING OPIOIDS
In 2022, the CDC updated its guidelines for prescribing opioids for the treatment of pain. Whereas the 2016 guideline focused on recommendations for primary care physicians, the newer guideline was expanded to include additional clinicians whose scope of practice includes prescribing opioids (e.g., physicians, nurse practitioners and other advanced-practice registered nurses, physician assistants, and oral health practitioners) (Dowell et al., 2022). (See “Resources” at the end of this course.)
Management of Opioid Overdose
Due to their pharmacologic effects, opioids in high doses can cause respiratory depression and death. Most drug-related deaths worldwide are attributable to opioids. Signs of opioid overdose include:
- Small, constricted “pinpoint pupils”
- Losing consciousness, unresponsiveness
- Slow, gargled breathing or no breathing
- Choking or gurgling sounds
- Limp body
- Cold or clammy skin
- Blue lips or nails
(CDC, 2024)
Combining opioids with alcohol and sedative medication increases the risk of respiratory depression; and combinations of opioids, alcohol, and sedatives are often present in fatal drug overdoses (WHO, 2023).
It is important to consider opiate overdose or toxicity in a lethargic patient with no other identifiable cause. Care of the patient at the scene depends on the vital signs. If the patient is comatose and in respiratory distress, airway control must be obtained prior to any other action. Endotracheal intubation is highly recommended for all patients unable to protect their airways.
If there is a suspicion of opiate overdose, naloxone is administered to reverse respiratory depression. Naloxone, an opioid antagonist, rapidly reverses an opioid overdose. One should be aware that naloxone can also cause agitation and aggression when it reverses the opiate.
Naloxone can reverse the effects of an overdose from opioids, including:
- Heroin
- Morphine
- Oxycodone (Oxycontin)
- Methadone
- Fentanyl
- Hydrocodone (Vicodin)
- Codeine
- Hydromorphone
Candidates for naloxone include individuals who are concerned about the risk of an opioid overdose, including people who use prescription or illicit opioids, their family members, friends, caregivers, and concerned members of the public. This includes patients:
- Receiving >50 mg morphine milligram equivalent (MME) of opioid treatment
- With a respiratory condition (e.g., COPD, asthma, sleep apnea)
- Who smoke marijuana, hookah, tobacco, etc.
- Being treated for opioid use disorder (DSM‐V)
- With a personal or family history of substance misuse (alcohol or drugs)
- Released after having experienced an opioid overdose
- Taking benzodiazepines, hypnotics, muscle relaxers, or other sedative use
- Being switched between opioid product formulations
- With difficult access to emergency services (e.g., rural)
- With heavy alcohol use
- By voluntary request from patient or caregiver
(SAMHSA, 2023; WV DHHR, 2025)
If the patient is a known drug abuser, the lowest dose of naloxone to reverse respiratory distress should be administered. In the ambulance, the patient may become combative or violent, and use of restraints may be required. If the individual has no intravenous access, naloxone can be administered intramuscularly, intranasally, intraosseous, or via the endotracheal tube. Data show that the intranasal route is as effective as the intramuscular route in the prehospital setting (Regina et al., 2025; Schiller et al., 2022).
Patient education includes showing patients, their family members, or caregivers how to administer naloxone. The medication can be given by intranasal spray or intramuscular, subcutaneous, or intravenous injection.
Patients given an automatic injection device or nasal spray should keep the item available at all times. The medication must be replaced when the expiration date passes and if exposed to temperatures below 39 °F or above 104 °F.
Side effects of naloxone may include an allergic reaction from naloxone, such as hives or swelling in the face, lips, or throat, for which medical help should be sought immediately. Use of naloxone also causes symptoms of opioid withdrawal. Opioid withdrawal symptoms include:
- Feeling nervous, restless, or irritable
- Body aches
- Dizziness or weakness
- Diarrhea, stomach pain, or nausea
- Fever, chills, or goose bumps
- Sneezing or runny nose in the absence of a cold
Since naloxone is a temporary treatment and its effects will wear off, medical assistance must be obtained as soon as possible after administering/receiving naloxone (Veteran Affairs, 2024).
MICHIGAN’S GOOD SAMARITAN LAW
Michigan’s Good Samaritan Law prevents drug possession charges against those that seek medical assistance for an overdose in certain circumstances. This law makes saving lives the priority during a drug overdose, not criminal prosecutions of illegal drug users (MDHHS, 2025a).
Identifying Drug-Seeking Patients
Most patients who complain of pain are honestly seeking relief from discomfort. Others seek drugs in order to cope with addiction or to provide income. Differentiating between the two can be very difficult.
Drug seekers include people of every age, gender, and socioeconomic status. Often these people initially used prescription drugs for valid medical conditions, and drug-seeking behaviors may have developed as a result of disease progression, undertreatment of pain, tolerance to the medication, or unrecognized addiction. Only a small number of drug seekers do so to divert opioids for illicit sale.
Some common characteristics can provide clues regarding the nature of a patient’s intent. The patient who is drug seeking may:
- Come from a location that is far away, perhaps across state lines
- Have seen many doctors in a short period of time
- Present with specific complaints that are often subjective (back pain, headache)
- Bring old medical records they have been carrying around to many different doctors to get a pain prescription
- Use multiple pharmacies
- Claim an allergy to all pain medications except the one they are seeking as well as to diagnostic test contrast medium to avoid tests
- Suggest the medication, dose, and quantity being sought
- Be unwilling to consider any other treatments and not want to listen to anything the clinician has to say
- Call or show up requesting a prescription at off hours, when the office is closing, or right before the weekend/holiday when it is less likely their usual care provider(s) can be reached
- Lie or tell a story that does not make sense (it is imperative to take a detailed history to look for inconsistencies in a made-up story)
- Exaggerate symptoms, with inconsistent behavior from waiting room to treatment room
- Become aggressive when different medications are suggested
- Give false information, such as a fake address or a disconnected phone number
- Be on multiple controlled substances, such as opioids and benzodiazepines
- Be excessively talkative, friendly, or helpful
However, drug-seeking patients with addictions are not the only ones who may engage in these behaviors. Over time, patients with true chronic pain can elicit some of these same behaviors (Girgis, 2022).
DRUG DIVERSION AND ADDICTION AMONG HEALTHCARE PROFESSIONALS
Because healthcare professionals are trusted with others’ health and well-being, they are not often suspected of drug addiction themselves; however, they are just as likely as anyone else to become addicted and are at a higher risk for addictive behaviors involving opioids because of their increased access to them.
It is a legal and ethical responsibility for healthcare professionals to uphold the law and to help protect society from drug abuse, and it is a professional responsibility to prescribe and dispense controlled substances appropriately, guarding against abuse while ensuring that patients have medication available when it is needed. Each healthcare professional also has a personal responsibility to protect their practice from becoming an easy target for drug diversion and must be aware of the potential situations where it can occur and the safeguards that can be utilized to prevent such diversion.
When the signs and symptoms of drug abuse are evident in a colleague, it is time to become concerned and involved, taking the following steps:
- Check the agency’s written drug and alcohol policy and follow recommendations.
- Document suspicions regarding the colleague, including any complaints, concerns, behavior patterns, or witnesses to behaviors.
- Bring concerns to management.
Addressing Pain in Individuals with Substance Use Disorders (SUDs)
Opioid use for pain management in patients with a history of SUDs may be considered if their use is carefully managed. This involves selecting the appropriate opioid, dosage titration, treatment agreements, and testing and monitoring.
When choosing the appropriate opioid, providers should select a medication that is safe and start with a low dose to ease pain, then titrate as needed to maintain pain relief without decreasing function or risking addiction or relapse.
When an effective dose has been determined, total opioid dose is increased slowly and only if needed, as tolerance develops. When monitoring for dosage, providers must be aware of both tolerance and hyperalgesia concerns. Tolerance can occur regardless of opioid type, dosage, route of administration, and dosage schedule. Clinicians should be aware that hyperalgesia, or oversensitivity to pain, can occur in some patients using opioids for chronic pain.
When patients develop tolerance to the analgesic effects of a particular opioid, providers can consider either escalating the dosage or switching from one opioid to another at a low dose that will effectively relieve pain without increasing the risk of relapse.
Before initiating opioid treatment, providers should determine whether the patient has access to a naloxone kit and prescribe one if they do not. (See also “Management of Opioid Overdose” earlier in this course.)
Before introducing any opioids into a patient’s treatment regimen, an assessment is done to determine the patient’s risk for developing a substance abuse disorder (SUD).
Screening tools available to clinicians include:
- Opioid Risk Tool (ORT)
- Drug Abuse Screen Test (DAST-10 and DAST-20 for adolescents)
- Screener and Opioid Assessment for Patient with Pain-Revised (SOAPP-R)
- Brief Screener for Alcohol, Tobacco, and other Drugs (BSTAD)
These tools, however, commonly result in inaccurate findings and misinterpretations. For instance, since screening tools often rely on a patient’s self-report, a patient may falsify responses on questionnaires to avoid detection as a high-risk patient.
Other recommendations include drug testing, primarily urine screening. Drug testing offers a critical adjunct to clinical assessment of SUD risk. However, due to the ease with which samples can be adulterated, providers must carefully review their collection protocols and sample validation procedures to ensure optimal accuracy, which may require observed collection (NIDA, 2023a; Rosenquist, 2024).
CONCLUSION
Pain is a universal human experience, the strongest motivator for an individual to seek medical care, and one of the body’s most important protective mechanisms. For the past several decades researchers have been hard at work discovering exactly what pain is and how to prevent it or alleviate it.
It is imperative that healthcare professionals understand their role in managing pain as one of their primary obligations and responsibilities. It is the duty of all involved in caring for patients in pain to do everything possible to bring them relief. To do less is to fail to provide quality patient care. In order to best carry out this responsibility, it is necessary for all professionals to continue to expand their knowledge and skills in managing this crucial healthcare issue.
RESOURCES
American Academy of Pain Medicine
American Society for Pain Management Nursing
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
Guidelines on the Management of Chronic Pain in Children (WHO)
REFERENCES
Ability KC. (2025). Phantom limb syndrome: What is it and how can it affect someone after amputation? https://abilitykc.org/phantom-limb-syndrome-what-is-it-and-how-can-it-affect-someone-after-amputation/
American Psychological Association (APA). (2025). Substance use, abuse, and addiction. https://www.apa.org/topics/substance-use-abuse-addiction
American Society of Health-System Pharmacists (ASHP). (2025). Controlled substances drug diversion toolkit. https://www.ashp.org/pharmacy-technicians/about-pharmacy-technicians/advanced-pharmacy-technician-roles-toolkits/controlled-substances-drug-diversion-pharmacy-technician-toolkit
Americans for Safe Access (ASA). (2023). 2022 state of the states report: An analysis of medical cannabis access in the United States. https://assets.nationbuilder.com/americansforsafeaccess/pages/27187/attachments/original/1675362731/StateoftheStates22_P5.pdf
Beaumont Health. (2024). Types of pain. https://www.beaumont.org/services/pain-management-services/types-of-pain
Borras-Fernandez I, Cruz-Jimenez M, Soto-Quijano D, Perez-Curet E, Rivera-Dones A, Blanco-Cintron A, & Diaz-Guevara B. (2025). Functional assessment. PM&R Knowledge Now. https://now.aapmr.org/functional-assessment/
Bukstein O. (2024). Approach to treating substance use disorder in adolescents. UpToDate. https://www.uptodate.com/contents/approach-to-treating-substance-use-disorder-in-adolescents
California Resource Learning Network (CRLN). (2024). What is psychosocial history? https://www.clrn.org/what-is-psychosocial-history/
Centers for Disease Control and Prevention (CDC). (2024). Chronic pain and high-impact chronic pain among U.S. adults, 2023. https://www.cdc.gov/nchs/products/databriefs/db518.htm
Cleveland Clinic. (2022). Psychogenic pain. https://my.clevelandclinic.org/health/diseases/12056-pain-psychogenic-pain
Comprehensive MedPsych Systems. (2025). Pain. https://www.medpsych.net/pain/
Crozer Health. (2022). PQRST pain assessment method. https://www.crozerhealth.org/nurses/pqrst/
Department of Health, Western Australia (DHWA). (2023). Yoga and pain. https://painhealth.csse.uwa.edu.au/pain-module/yoga/
Dowell D, Ragan KR, Jones CM, Baldwin GT, & Chou R. (2022). CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep, 71(RR-3), 1–95. http://dx.doi.org/10.15585/mmwr.rr7103a1
Drugs.com. (2025). Journavx. https://www.drugs.com/journavx.html
Dunkin MA. (2024). Hypnosis, meditation, and relaxation for pain. WebMD. https://www.webmd.com/pain-management/hypnosis-meditation-and-relaxation-for-pain-treatment
Eley W. (2023). How does virtual reality affect the brain? Robots.net. https://robots.net/tech/how-does-virtual-reality-affect-the-brain/
Fortis Healthcare. (2025). What are idiopathic diseases and how do they impact people? https://www.fortishealthcare.com/blogs/what-are-idiopathic-diseases-and-how-do-they-impact-people
Girgis L. (2022). Is your patient a drug seeker? 13 red flags to watch for. Medical Economics. https://www.medicaleconomics.com/view/your-patient-drug-seeker-13-red-flags-watch?page=14
Glasofer D. (2024). What is acceptance and commitment therapy (ACT)? Verywellmind. https://www.verywellmind.com/acceptance-commitment-therapy-gad-1393175
Gooch CL & Henderson R. (2025). Overview of electromyography. UpToDate. https://www.uptodate.com/contents/overview-of-electromyography
International Association for the Study of Pain (IASP). (2021). Access to pain management: Declaration of Montreal. http://www.iasp-pain.org/DeclarationofMontreal?navItemNumber=582
Jamison R & Craig K. (2022). Chapter 11: Psychological assessment of persons with chronic pain. In M Lyn, K Craig, & P Peng (Eds.), Clinical pain management: A practical guide (2nd ed.). John Wiley & Sons.
Jimenez A. (2025). Using blood tests to determine the underlying cause of back pain. Sciatica.Clinic. https://sciatica.clinic/using-blood-tests-to-determine-the-underlying-cause-of-back-pain/
Johns Hopkins Medicine. (2025). Palliative care methods for controlling pain. https://www.hopkinsmedicine.org/health/wellness-and-prevention/palliative-care-methods-for-controlling-pain
Kaiser Family Foundation (KFF). (2025). Mental health in Michigan. https://www.kff.org/statedata/mental-health-and-substance-use-state-fact-sheets/michigan/
LeWine H. (2024). Understanding the stress response: Chronic activation of this survival mechanism impairs health. Harvard Health Publishing. https://www.health.harvard.edu/staying-healthy/understanding-the-stress-response
Lucchetti L. (2023). Mindfulness-based stress reduction: What to know. MedicalNewsToday. https://www.medicalnewstoday.com/articles/mindfulness-based-stress-reduction
Maddox T, Oldstone L, Linde-Zwirble W, Bonakdar R, Maddox R, Sackman J, Adair T, French K, Sparks C, & Darnall B. (2025). Differential treatment response to virtual reality in high-impact chronic pain: Secondary analysis of a randomized trial. Sci Rep, 15, 14430. https://www.nature.com/articles/s41598-025-98716-3#citeas
Marks JL. (2022). Qigong and tai chi to help chronic pain. Everyday Health. https://www.everydayhealth.com/chronic-pain/qigong-and-tai-chi-how-can-they-help-chronic-pain/
Mayo Clinic. (2024a). Relaxation techniques: Try these steps to lower stress. https://www.mayoclinic.org/healthy-lifestyle/stress-management/in-depth/relaxation-technique/art-20045368
Mayo Clinic. (2024b). Tests and procedures. https://www.mayoclinic.org/departments-centers/pain-medicine/sections/tests-procedures/orc-20450074
Meldrum M. (2025). Pain. Britannica. https://www.britannica.com/science/pain
Michigan Department of Health & Human Services (MDHHS). (2025a). Michigan's good Samaritan law. https://www.michigan.gov/opioids/nel/laws
Michigan Department of Health and Human Services (MDHHS). (2025b). Michigan projects third consecutive year of decline in opioid overdose deaths. https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2025/06/05/michigan-projects-third-consecutive-year-of-decline-in-opioid-overdose-deaths
National Center for Complementary and Integrative Health (NCCIH). (2025). Pain. https://nccih.nih.gov/health/pain
National Center for Drug Abuse Statistics (NCDAS). (2025). Prescription drug abuse statistics. https://drugabusestatistics.org/prescription-drug-abuse-statistics/
National Institute on Drug Abuse (NIDA). (2025). A new roadmap for cannabis and cannabis policy research. https://nida.nih.gov/about-nida/noras-blog/2025/01/new-roadmap-cannabis-cannabis-policy-research
National Institute on Drug Abuse (NIDA). (2023a). Screening and assessment tools chart. https://nida.nih.gov/nidamed-medical-health-professionals/screening-tools-resources/chart-screening-tools
National Institute on Drug Abuse (NIDA). (2023b). What is the scope of prescription drug misuse in the United States? https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-scope-prescription-drug-misuse
Nnanna O. (2022). Blood tests to identify medical causes of neuropathy. Neuropathy Commons. https://neuropathycommons.org/get-tested/blood-tests
NORML. (2025). Michigan laws and penalties. https://norml.org/laws/michigan-penalties-2/
Oregon Alcohol and Drug Policy Commission (OR ADPC). (2025). Opiates or opioids—What’s the difference? Oregon.gov. https://www.oregon.gov/adpc/pages/opiate-opioid.aspx
Physiopedia. (2025a). Behavioural approaches to pain management. https://www.physio-pedia.com/Behavioural_Approaches_to_Pain_Management
Physiopedia. (2025b). Mirror therapy. https://www.physio-pedia.com/Mirror_Therapy
Pogatzki-Zahn E, De Lucia S, Weinmann C, Heitkamp H, Hummelshoj L, Liedgens H, Meissner W, Vincent K, Vollert J, Zahn P, Kaiser U, & Rosenberger D. (2025). A core outcome set of measurement instruments for assessing effectiveness and efficacy of perioperative pain management: Results of the international IMI-PainCare PROMPT Delphi consensus process. Br J Anaesth, 134(5), 1460–1473. https://www.bjanaesthesia.org/article/S0007-0912(25)00089-3/fulltext
Portenoy R, Ahmed E, & Keilson Y. (2022). Cancer pain management: Role of adjuvant analgesics (coanalgesics). UpToDate. https://www.uptodate.com/contents/cancer-pain-management-role-of-adjuvant-analgesics-coanalgesics
Portenoy R & Dhingra L. (2022). Assessment of cancer pain. UpToDate. https://www.uptodate.com/contents/assessment-of-cancer-pain
ProAssurance (2023). Strategies for managing drug-seeking patients. https://www.norcal-group.com/library/strategies-for-managing-drug-seeking-patients
Regina A, Goyal A, & Mechanic O. (2025). Opioid toxicity. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK470415/
Robles E, Blanco I, Diez G, & Vazquez C. (2024). Mindfulness-based stress reduction for chronic pain: Enhancing psychological well-being without altering intentional biases towards pain faces. Eur J Pain, 29(2), Article e4714. https://pmc.ncbi.nlm.nih.gov/articles/PMC11671333/
Rosenquist R. (2024). Revised screener and opioid assessment for patients with pain (SOAPP-R). UpToDate. https://www.uptodate.com/contents/use-of-opioids-in-the-management-of-chronic-non-cancer-pain
Schiller E, Goyal A, & Mechanic O. (2022). Opioid overdose. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK470415/
Schreiber J & Culpepper L. (2023). Suicidal ideation and behavior in adults. UpToDate. https://www.uptodate.com/contents/suicidal-ideation-and-behavior-in-adults?search=#H17
Sevarino K. (2023). Opioid withdrawal in adults: Clinical features, assessment, and diagnosis. UpToDate. https://www.uptodate.com/contents/opioid-withdrawal-clinical-features-assessment-and-diagnosis
Slater H & Davies S. (2023). Pain types. painHEALTH. https://painhealth.csse.uwa.edu.au/pain-module/pain-types/
Stanford Health Care. (2025). Management of pain without medications. https://stanfordhealthcare.org/medical-conditions/pain/pain/treatments/non-pharmacological-pain-management.html
State of Michigan Department of Community Health. (n.d.). Michigan board of nursing guidelines for the use of controlled substances for the treatment of pain. https://www.michigan.gov/lara/-/media/Project/Websites/lara/bpl/Nursing/Licensing-Info-and-Forms/Nursing-Guidelines-for-the-Use-of-Controlled-Substances-for-the-Treatment-of-Pain.pdf
Substance Abuse and Mental Health Services Administration (SAMHSA). (2023). Non-prescription (“over-the-counter”) naloxone frequently asked questions. https://www.samhsa.gov/substance-use/treatment/overdose-prevention/otc-naloxone-faqs
Sureja RN. (2025). Idiopathic pain: Pain with no specific cause. Orthopaedic & Spine Center. https://www.osc-ortho.com/blog/idiopathic-pain-pain-with-no-specific-cause/
Tauben D & Stacey B. (2025). Evaluation of chronic non-cancer pain in adults. UpToDate. https://www.uptodate.com/contents/evaluation-of-chronic-non-cancer-pain-in-adults
TEMA Therapy Center. (2025). Beyond physical pain: How chronic pain impacts mental health and what you can do about it. https://tematherapy.com/beyond-physical-pain-how-chronic-pain-impacts-mental-health-and-what-you-can-do-about-it/
Toney-Butler T. (2023). Nursing admission assessment and examination. StatPearls [Internet]. https://www.statpearls.com/kb/viewarticle/41082/
U.S. Food and Drug Administration (U.S. FDA). (2025). FDA approves novel non-opioid treatment for moderate to severe acute pain. https://www.fda.gov/news-events/press-announcements/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain
Vertex. (2025). Vertex announces FDA approval of JOURNAVAX (suzetrigine), a first-in-class treatment for adults with moderate-to-severe acute pain. https://news.vrtx.com/news-releases/news-release-details/vertex-announces-fda-approval-journavxtm-suzetrigine-first-class
Veteran Affairs. (2024). Naloxone rescue: Recommendations for use. https://www.va.gov/formularyadvisor/DOC_PDF/CRE_Naloxone_Rescue_Guidance_March_2024.pdf
Victoria Department of Health. (2024). Pain in older people. https://www.health.vic.gov.au/older-people-in-hospital/pain-in-older-people
Watson S. (2024). Overview of biofeedback. WebMD. https://www.webmd.com/pain-management/biofeedback-therapy-uses-benefits
West Virginia Department of Health and Human Resources (WV DHHR). (2025). Naloxone. http://sempguidelines.org/wp-content/uploads/2017/04/Naloxone-Handout.pdf
Wheeler T. (2023). How do doctors find the cause of pain? WebMD. https://www.webmd.com/pain-management/guide/pain-management-diagnosing
Wood E. (2025). On the pulse: The top 8 benefits of PEMF therapy. Rehabmart.com. https://www.rehabmart.com/post/benefits-pemf-therapy
World Health Organization (WHO). (2023). Opioid overdose. https://www.who.int/news-room/fact-sheets/detail/opioid-overdose

Customer Rating
4.9 / 81 ratings